Journals A-Z
All Subjects
Free Journals
sciepub.com
International Journal of Celiac Disease
ISSN (Print): 2334-3427 ISSN (Online): 2334-3486 Website: https://www.sciepub.com/journal/ijcd Editor-in-chief: Samasca Gabriel
Open Access
Journal Browser
Go
Issue 1, Volume 10
Article Metrics
  • 4940
    Views
  • 5735
    Saves
  • 0
    Citations
  • 7
    Likes
Export Article
International Journal of Celiac Disease. 2022, 10(1), 22-38
DOI: 10.12691/ijcd-10-1-3
Open AccessArticle

Impact of the COVID-19 Pandemic in Romanian Celiac Disease Patients by E-Survey

Vasile Daniel Balaban1, 2, Alina Dima3, , Catalin Augustin Dima1, 2, Alina Popp1, 4, Ciprian Jurcut2 and Mariana Jinga1, 2

1Carol Davila University of Medicine and Pharmacy, Bucharest, Romania

2Dr Carol Davila Central University Emergency Military Hospital, Bucharest, Romania

3Colentina Clinical Hospital, Bucharest, Romania

4National Institute for Mother and Child Health, Bucharest, Romania

Pub. Date: September 05, 2022
View Full Text Full Text PDF (308 KB) Full Text ePUB(323 KB)

Cite this paper:
Vasile Daniel Balaban, Alina Dima, Catalin Augustin Dima, Alina Popp, Ciprian Jurcut and Mariana Jinga. Impact of the COVID-19 Pandemic in Romanian Celiac Disease Patients by E-Survey. International Journal of Celiac Disease. 2022; 10(1):22-38. doi: 10.12691/ijcd-10-1-3

Abstract

Background: The coronavirus disease 2019 (COVID-19) pandemic has immeasurably struck healthcare systems worldwide, generating disruptions in the care of chronic disease patients. We herein aimed to assess the impact of the COVID-19 pandemic on celiac disease (CD) patients. Materials and Methods: An online questionnaire with 46 cascade questions was designed and distributed through the social media channel of the Romanian CD patient association. Results: Altogether, 113 respondents accessed the questionnaire, of whom 95 adult CD patients with complete responses were included in the analysis. The median age of the surveyed participants was 44 years, with the majority (86.3%) being female. Despite concerns, the availability of gluten-free products was reported as being unchanged compared to before the pandemic by 3 out of 4 respondents. Also, our survey did not reveal significant changes regarding adherence to gluten-free diet during the pandemic, as assessed by Biagi score. However, 25.3% of respondents reported feelings of anxiety and 29.5% of depression, but only 3.2% benefited from psychological or psychiatric support. About one quarter of participants postponed their medical checkups due to fear of getting infected. One fifth of respondents declared having been infected with the novel coronavirus, but only 10% of them were hospitalized. One third of respondents had already gotten the COVID-19 vaccine and reported only minor side effects. Also, over half (57.9%) of survey participants declared they had not received enough information during the pandemic. Conclusions: Among our study respondents, availability and adherence to gluten-free diet was not markedly changed during the pandemic, but they were significantly impacted by the lack of CD-specific information about SARS-CoV2 infection and vaccination.

Keywords:
celiac disease pandemic COVID-19 gluten-free diet vaccination

Creative CommonsThis work is licensed under a Creative Commons Attribution 4.0 International License. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/

References:

[1]  WHO Director-General’s opening remarks at the media briefing on COVID-19 - 11 March 2020 [Internet]. [cited 2020 Dec 2]. Available from: https://www.who.int/director-general/speeches/detail/who-director-general-s-opening-remarks-at-the-media-briefing-on-covid-19---11-march-2020.
 
[2]  Xia Y, Li Q, Li W, Shen H. Elevated mortality of chronic diseases during COVID-19 pandemic: a cause for concern? Ther Adv Chronic Dis. 2020; 11.
 
[3]  Danhieux K, Buffel V, Pairon A, Benkheil A, Remmen R, Wouters E, et al. The impact of COVID-19 on chronic care according to providers: a qualitative study among primary care practices in Belgium. BMC Fam Pract 2020 211. 2020 Dec 5; 21(1): 1-6.
 
[4]  Guidry JPD, Carlyle KE, Miller CA, Ksinan AJ, Winn R, Sheppard VB, et al. Endorsement of COVID-19 related misinformation among cancer survivors. Patient Educ Couns. 2021 May 21.
 
[5]  Jayasinghe R, Ranasinghe S, Jayarajah U, Seneviratne S. Quality of online information for the general public on COVID-19. Patient Educ Couns. 2020 Dec 1; 103(12): 2594-7.
 
[6]  Singh P, Arora A, Strand TA, Leffler DA, Catassi C, Green PH, et al. Global Prevalence of Celiac Disease: Systematic Review and Meta-analysis. Clin Gastroenterol Hepatol Off Clin Pract J Am Gastroenterol Assoc. 2018 Jun 1; 16(6): 823-836.e2.
 
[7]  Murray JA, Van Dyke C, Plevak MF, Dierkhising RA, Zinsmeister AR, Melton LJ. Trends in the identification and clinical features of celiac disease in a North American community, 1950-2001. Clin Gastroenterol Hepatol Off Clin Pract J Am Gastroenterol Assoc. 2003 Jan; 1(1): 19-27.
 
[8]  Al-Toma A, Volta U, Auricchio R, Castillejo G, Sanders DS, Cellier C, et al. European Society for the Study of Coeliac Disease (ESsCD) guideline for coeliac disease and other gluten-related disorders. United Eur Gastroenterol J. 2019 Jun; 7(5): 583-613.
 
[9]  Husby S, Koletzko S, Korponay-Szabó I, Kurppa K, Mearin ML, Ribes-Koninckx C, et al. European Society Paediatric Gastroenterology, Hepatology and Nutrition Guidelines for Diagnosing Coeliac Disease 2020. J Pediatr Gastroenterol Nutr. 2020 Jan; 70(1): 141-56.
 
[10]  Hamming I, Timens W, Bulthuis ML, Lely AT, Navis G, van Goor H. Tissue distribution of ACE2 protein, the functional receptor for SARS coronavirus. A first step in understanding SARS pathogenesis. J Pathol. 2004 Jun; 203(2): 631-7.
 
[11]  Dima A, Balaban DV, Jurcut C, Berza I, Jurcut R, Jinga M. Article perceptions of romanian physicians on lockdowns for covid-19 prevention. Healthc Switz. 2021 Jan 18; 9(1): 95.
 
[12]  Valitutti F, Toncone R, Pisano P, Ciacci C. Where have all the other coeliacs gone in 2020? Road for a 2021 catch-up with missed diagnoses. Dig Liver Dis Off J Ital Soc Gastroenterol Ital Assoc Study Liver. 2021 Apr 1; 53(4): 504-5.
 
[13]  Catassi GN, Vallorani M, Cerioni F, Lionetti E, Catassi C. A negative fallout of COVID-19 lockdown in Italy: Life-threatening delay in the diagnosis of celiac disease. Dig Liver Dis. 2020 Oct 1; 52(10): 1092.
 
[14]  Eysenbach G. Improving the quality of Web surveys: the Checklist for Reporting Results of Internet E-Surveys (CHERRIES). J Med Internet Res. 2004 Sep 29; 6(3): e34.
 
[15]  Biagi F, Andrealli A, Bianchi PI, Marchese A, Klersy C, Corazza GR. A gluten-free diet score to evaluate dietary compliance in patients with coeliac disease. Br J Nutr. 2009 Sep; 102(6): 882-7.
 
[16]  Dong E, Du H, Gardner L. An interactive web-based dashboard to track COVID-19 in real time. Lancet Infect Dis. 2020 May 1; 20(5): 533-4.
 
[17]  HOTARARE 293 10/03/2021 - Portal Legislativ [Internet]. [cited 2021 Jul 18]. Available from: http://legislatie.just.ro/Public/DetaliiDocumentAfis/239080.
 
[18]  Leao T, Amorim M, Fraga S, Barros H. What doubts, concerns and fears about COVID-19 emerged during the first wave of the pandemic? Patient Educ Couns. 2021 Feb 1; 104(2): 235-41.
 
[19]  Falcomer AL, Farage P, Pratesi CB, Pratesi R, Gandolfi L, Nakano EY, et al. Health-Related Quality of Life and Experiences of Brazilian Celiac Individuals over the Course of the Sars-Cov-2 Pandemic. Nutr 2021 Vol 13 Page 1582. 2021 May 9; 13(5): 1582.
 
[20]  Monzani A, Lionetti E, Felici E, Fransos L, Azzolini D, Rabbone I, Catassi C. Adherence to the Gluten-Free Diet during the Lockdown for COVID-19 Pandemic: A Web-Based Survey of Italian Subjects with Celiac Disease. Nutrients. 2020 Nov 1; 12(11): 1-12.
 
[21]  Bascuñán KA, Rodríguez JM, Osben C, Fernández A, Sepúlveda C, Araya M. Pandemic Effects and Gluten-Free Diet: An Adherence and Mental Health Problem. Nutr 2021 Vol 13 Page 1822. 2021 May 27; 13(6): 1822.
 
[22]  Mårild K, Fredlund H, Ludvigsson JF. Increased risk of hospital admission for influenza in patients with celiac disease: a nationwide cohort study in Sweden. Am J Gastroenterol. 2010 Nov; 105(11): 2465-73.
 
[23]  Ludvigsson JF, Wahlstrom J, Grunewald J, Ekbom A, Montgomery SM. Coeliac disease and risk of tuberculosis: a population based cohort study. Thorax. 2007 Jan; 62(1): 23-8.
 
[24]  Simons M, Scott-Sheldon LAJ, Risech-Neyman Y, Moss SF, Ludvigsson JF, Green PHR. Celiac Disease and Increased Risk of Pneumococcal Infection: A Systematic Review and Meta-Analysis. Am J Med. 2018 Jan; 131(1): 83-9.
 
[25]  Ludvigsson JF, Choung RS, Marietta EV, Murray JA, Emilsson L. Increased risk of herpes zoster in patients with coeliac disease - nationwide cohort study. Scand J Public Health. 2018 Dec; 46(8): 859-66.
 
[26]  Canova C, Ludvigsson J, Baldo V, Barbiellini Amidei C, Zanier L, Zingone F. Risk of bacterial pneumonia and pneumococcal infection in youths with celiac disease - A population-based study. Dig Liver Dis Off J Ital Soc Gastroenterol Ital Assoc Study Liver. 2019 Aug; 51(8): 1101-5.
 
[27]  Zingone F, Abdul Sultan A, Crooks CJ, Tata LJ, Ciacci C, West J. The risk of community-acquired pneumonia among 9803 patients with coeliac disease compared to the general population: a cohort study. Aliment Pharmacol Ther. 2016 Jul; 44(1): 57-67.
 
[28]  Ludvigsson JF, Sanders DS, Maeurer M, Jonsson J, Grunewald J, Wahlström J. Risk of tuberculosis in a large sample of patients with coeliac disease--a nationwide cohort study. Aliment Pharmacol Ther. 2011 Mar; 33(6): 689-96.
 
[29]  B L, PHR G, J S, B R, JF L. Association Between Celiac Disease and Mortality Risk in a Swedish Population. JAMA. 2020 Apr 7; 323(13): 1277-85.
 
[30]  Di Sabatino A, Rosado MM, Cazzola P, Riboni R, Biagi F, Carsetti R, et al. Splenic hypofunction and the spectrum of autoimmune and malignant complications in celiac disease. Clin Gastroenterol Hepatol Off Clin Pract J Am Gastroenterol Assoc. 2006 Feb; 4(2): 179-86.
 
[31]  William BM, Corazza GR. Hyposplenism: a comprehensive review. Part I: basic concepts and causes. Hematol Amst Neth. 2007 Feb; 12(1): 1-13.
 
[32]  Di Sabatino A, Carsetti R, Corazza GR. Post-splenectomy and hyposplenic states. Lancet Lond Engl. 2011 Jul 2; 378(9785): 86-97.
 
[33]  Giuffrida P, Aronico N, Rosselli M, Lenti MV, Cococcia S, Roccarina D, et al. Defective spleen function in autoimmune gastrointestinal disorders. Intern Emerg Med. 2020 Mar; 15(2): 225-9.
 
[34]  Pascolini S, Vannini A, Deleonardi G, Ciordinik M, Sensoli A, Carletti I, et al. COVID-19 and Immunological Dysregulation: Can Autoantibodies be Useful? Clin Transl Sci. 2021 Mar; 14(2): 502-8.
 
[35]  Zhen J, Stefanolo JP, Temprano M de la P, Tedesco S, Seiler C, Caminero AF, et al. The Risk of Contracting COVID-19 Is Not Increased in Patients With Celiac Disease. Clin Gastroenterol Hepatol. 2021 Feb 1; 19(2): 391-3.
 
[36]  Lebwohl B, Larsson E, Söderling J, Roelstraete B, Murray JA, Green PHR, et al. Risk of Severe Covid-19 in Patients with Celiac Disease: A Population-Based Cohort Study. Clin Epidemiol. 2021; 13: 121-30.
 
[37]  Schiepatti A, Alimenti E, Maimaris S, Nicolardi ML, Manzella La Barbera F, Baiardi P, et al. Prevalence, incidence and clinical features of SARS-CoV-2 infection in adult coeliac patients. Eur J Gastroenterol Hepatol. 2021; Publish Ah(June): 1-6.
 
[38]  Zingone F, D’Odorico A, Lorenzon G, Marsilio I, Farinati F, Savarino EV. Risk of COVID-19 in celiac disease patients. Autoimmun Rev. 2020 Oct; 19(10): 102639.
 
[39]  Lerner, Aaron. The COVID-19 Vaccination Debate: CoV-2 in Celiac Disease: A Pathogen or just along for the Ride? Int J Celiac Dis. 2021; 9(1): 6-9.
 
[40]  Volta U, De Giorgio R, Granito A, Stanghellini V, Barbara G, Avoni P, et al. Anti-ganglioside antibodies in coeliac disease with neurological disorders. Dig Liver Dis Off J Ital Soc Gastroenterol Ital Assoc Study Liver. 2006 Mar; 38(3): 183-7.
 
[41]  Cervio E, Volta U, Verri M, Boschi F, Pastoris O, Granito A, et al. Sera of patients with celiac disease and neurologic disorders evoke a mitochondrial-dependent apoptosis in vitro. Gastroenterology. 2007 Jul; 133(1): 195-206.
 
[42]  Zhen J, Stefanolo JP, Temprano M de la P, Seiler CL, Caminero A, de-Madaria E, et al. Risk perception and knowledge of COVID-19 in patients with celiac disease. http://www.wjgnet.com/. 2021 Mar 28; 27(12): 1213-25.
 
[43]  T Z, S K. Psychoneuroimmunology--cross-talk between the immune and nervous systems. J Neurol. 2007 May; 254 Suppl 2(2 SUPPL.).
 
[44]  Siniscalchi M, Zingone F, Savarino EV, D’Odorico A, Ciacci C. COVID-19 pandemic perception in adults with celiac disease: an impulse to implement the use of telemedicine. Dig Liver Dis. 2020 Oct 1; 52(10): 1071.
 
[45]  Ionescu TC, Fetecau BI, Boscaiu V, Tudose C. Anxiety, Perceived Stress, and Resilience during the COVID-19 Pandemic: Population Estimates of Persons Presenting to a General Practitioner in Romania. Brain Sci. 2021 Nov 20; 11(11): 1541.
 
[46]  Wu T, Jia X, Shi H, Niu J, Yin X, Xie J, Wang X. Prevalence of mental health problems during the COVID-19 pandemic: A systematic review and meta-analysis. J Affect Disord. 2021 Feb 15; 281: 91-8.
 
[47]  Gokden Y, Hot S, Adas M, Ogutmen Koc D, Atak S, Hot AB. Celiac disease and COVID-19 pandemic : should we worry?
 
[48]  Trindade IA, Ferreira NB. COVID-19 Pandemic’s Effects on Disease and Psychological Outcomes of People With Inflammatory Bowel Disease in Portugal: A Preliminary Research. Inflamm Bowel Dis. 2021 Jul 27; 27(8): 1224-9.
 
[49]  Bertani L, Barberio B, Tricò D, Zanzi F, Maniero D, Ceccarelli L, et al. Hospitalisation for Drug Infusion Did Not Increase Levels of Anxiety and the Risk of Disease Relapse in Patients with Inflammatory Bowel Disease during COVID-19 Outbreak. J Clin Med. 2021 Jul 24; 10(15): 3270.
 
[50]  Medda E, Toccaceli V, Gigantesco A, Picardi A, Fagnani C, Stazi MA. The COVID-19 pandemic in Italy: Depressive symptoms immediately before and after the first lockdown. J Affect Disord. 2022 Feb 1; 298(Pt A): 202-8.
 
[51]  Elli L, Barisani D, Vaira V, Bardella MT, Topa M, Vecchi M, et al. How to manage celiac disease and gluten-free diet during the COVID-19 era: proposals from a tertiary referral center in a high-incidence scenario. BMC Gastroenterol. 2020 Nov 19; 20(1): 387.
 
[52]  Galli G, Esposito G, Dilaghi E, Annibale B, Lahner E, Conti L. Successful coping with SARS-CoV-2 infection of adult celiac patients assessed by telemedicine. Dig Liver Dis Off J Ital Soc Gastroenterol Ital Assoc Study Liver. 2021 Apr; 53(4): 391-3.
 
[53]  Costantino A, Roncoroni L, Noviello D, Nandi N, Lombardo V, Scricciolo A, et al. Nutritional and Gastroenterological Monitoring of Patients With Celiac Disease During COVID-19 Pandemic: The Emerging Role of Telemedicine and Point-of-Care Gluten Detection Tests. Front Nutr. 2021; 8: 622514.
 
[54]  Husby S, Bai JC. Follow-up of Celiac Disease. Gastroenterol Clin North Am. 2019 Mar 1; 48(1): 127-36.
 
[55]  Moya DA, Nugent CA, Baker RD, Baker SS. Celiac Disease Nutritional Status and Poor Adherence to Follow-up. Clin Pediatr (Phila). 2020 Jun 1; 59(7): 649-55.
 
[56]  Opri R, Veneri D, Mengoli C, Zanoni G. Immune response to Hepatitis B vaccine in patients with celiac disease: A systematic review and meta-analysis. Hum Vaccines Immunother. 2015 Jan 1; 11(12): 2800.
 
[57]  Balamtekın N, Uslu N, Baysoy G, Saltik-Temızel I, Demır H, Yüce A. Responsiveness of children with celiac disease to different hepatitis B vaccination protocols. Turk J Gastroenterol Off J Turk Soc Gastroenterol. 2011 Feb; 22(1): 27-31.
 
[58]  Costantino A, Topa M, Roncoroni L, Doneda L, Lombardo V, Stocco D, et al. COVID-19 Vaccine: A Survey of Hesitancy in Patients with Celiac Disease. Vaccines. 2021 May 1; 9(5).
 
[59]  Pinte L, Caraiola S, Balaban DV, Badea C, Mazilu D, Ionescu GD, et al. COVID-19 Impact and Vaccination Willingness among Romanian Patients with Autoimmune/Immune-Mediated Diseases. Healthc Basel Switz. 2021 Dec 8; 9(12): 1707.
 
[60]  Dima A, Jurcut C, Balaban DV, Gheorghita V, Jurcut R, Dima AC, et al. Physicians’ Experience with COVID-19 Vaccination: A Survey Study. Healthc Basel Switz. 2021 Dec 17; 9(12): 1746.
 
[61]  Elli L, Facciotti F, Lombardo V, Scricciolo A, Sanders DS, Vaira V, et al. Impact of a SARS-COV-2 Infection in Patients with Celiac Disease. medRxiv. 2020 Dec 16; 2020. 12.15. 20248039.
 
[62]  Pinte L, Negoi F, Ionescu GD, Caraiola S, Balaban DV, Badea C, et al. COVID-19 Vaccine Does Not Increase the Risk of Disease Flare-Ups among Patients with Autoimmune and Immune-Mediated Diseases. J Pers Med. 2021 Dec 2; 11(12): 1283.
 
[63]  Mathieu E, Ritchie H, Ortiz-Ospina E, Roser M, Hasell J, Appel C, et al. A global database of COVID-19 vaccinations. Nat Hum Behav.
 
[64]  Hale T, Angrist N, Goldszmidt R, Kira B, Petherick A, Phillips T, et al. A global panel database of pandemic policies (Oxford COVID-19 Government Response Tracker). Nat Hum Behav 2021 54. 2021 Mar 8; 5(4): 529-38.
 
[65]  Arámburo-Gálvez JG, Carvalho Gomes I, André TG, Beltrán-Cárdenas CE, Macêdo-Callou MA, Braga Rocha ÉM, Mye-Takamatu-Watanabe EA, Rahmeier-Fietz V, Figueroa-Salcido OG, Cárdenas-Torres FI, Ontiveros N, Cabrera-Chávez F. Translation, Cultural Adaptation, and Evaluation of a Brazilian Portuguese Questionnaire to Estimate the Self-Reported Prevalence of Gluten-Related Disorders and Adherence to Gluten-Free Diet. Med Kaunas Lith. 2019 Sep 1; 55(9).
 

rejection rate =

10%
Manuscript template